247 related articles for article (PubMed ID: 32277545)
21. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
23. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
24. High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies.
Rossignol J; Cozzi B; Liebaert F; Hatton S; Viallard ML; Hermine O; Greco C
Support Care Cancer; 2019 Aug; 27(8):3053-3059. PubMed ID: 30607681
[TBL] [Abstract][Full Text] [Related]
25. A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.
Vatandoust S; Joshi R; Pittman KB; Esterman A; Broadbridge V; Adams J; Singhal N; Yeend S; Price TJ
Support Care Cancer; 2014 Feb; 22(2):513-8. PubMed ID: 24122404
[TBL] [Abstract][Full Text] [Related]
26. Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN).
Argyriou AA
Toxics; 2015 May; 3(2):187-197. PubMed ID: 29056657
[TBL] [Abstract][Full Text] [Related]
27. Effect of Aromatherapy Massage on Chemotherapy-Induced Peripheral Neuropathic Pain and Fatigue in Patients Receiving Oxaliplatin: An Open Label Quasi-Randomized Controlled Pilot Study.
Izgu N; Ozdemir L; Bugdayci Basal F
Cancer Nurs; 2019; 42(2):139-147. PubMed ID: 29200001
[TBL] [Abstract][Full Text] [Related]
28. Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity.
Velasco R; Alemany M; Villagrán M; Argyriou AA
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357136
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population.
Zribi A; Nasr SB; Hamdi S; Ayari J; Fendri S; Balti M; Haddaoui A
Pan Afr Med J; 2020; 35():83. PubMed ID: 32537086
[TBL] [Abstract][Full Text] [Related]
30. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
[TBL] [Abstract][Full Text] [Related]
31. Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer.
Lucchetta M; Lonardi S; Bergamo F; Alberti P; Velasco R; Argyriou AA; Briani C; Bruna J; Cazzaniga M; Cortinovis D; Cavaletti G; Kalofonos HP
Cancer Chemother Pharmacol; 2012 Dec; 70(6):899-902. PubMed ID: 23108696
[TBL] [Abstract][Full Text] [Related]
32. TRPA1 and TRPM8 Receptors May Promote Local Vasodilation that Aggravates Oxaliplatin-Induced Peripheral Neuropathy Amenable to 17β-Estradiol Treatment.
Pan Y; Chen F; Huang S; Cai Z; Lan H; Tong Y; Yu X; Zhao G
Curr Neurovasc Res; 2016; 13(4):309-317. PubMed ID: 27262300
[TBL] [Abstract][Full Text] [Related]
33. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.
Yang YH; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Chang SC; Lan YT; Lin CC; Yen CC; Tzeng CH; Wang WS; Chiang HL; Teng CJ; Teng HW
Support Care Cancer; 2012 Jul; 20(7):1491-7. PubMed ID: 21814779
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study.
Kokotis P; Schmelz M; Kostouros E; Karandreas N; Dimopoulos MA
Clin Colorectal Cancer; 2016 Sep; 15(3):e133-40. PubMed ID: 27038553
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
36. The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey.
Ali NT; Mohamed AA; Yousef BA
Asia Pac J Oncol Nurs; 2020; 7(3):266-272. PubMed ID: 32642498
[TBL] [Abstract][Full Text] [Related]
37. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
Soveri LM; Lamminmäki A; Hänninen UA; Karhunen M; Bono P; Osterlund P
Acta Oncol; 2019 Apr; 58(4):398-406. PubMed ID: 30638100
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients.
Palugulla S; Devaraju P; Kayal S; Narayan SK; Mathaiyan J
Cancer Chemother Pharmacol; 2018 Sep; 82(3):421-428. PubMed ID: 29936608
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Velasco R; Besora S; Argyriou AA; Santos C; Sala R; Izquierdo C; Simó M; Gil-Gil M; Pardo B; Jiménez L; Clapés V; Calvo M; Palmero R; Bruna J
Anticancer Drugs; 2021 Jan; 32(1):88-94. PubMed ID: 33332891
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of sympathetic sprouting in CCD rats by lacosamide.
Wang Y; Huo F
Eur J Pain; 2018 Oct; 22(9):1641-1650. PubMed ID: 29758584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
